tiprankstipranks
Longeveron presents Lomecel-B long-term transplant-free survival data in HLHS
PremiumThe FlyLongeveron presents Lomecel-B long-term transplant-free survival data in HLHS
2M ago
Longeveron announces type C meeting with FDA for Lomecel-B BLA
Premium
The Fly
Longeveron announces type C meeting with FDA for Lomecel-B BLA
4M ago
Longeveron price target lowered to $6 from $15 at Maxim
Premium
The Fly
Longeveron price target lowered to $6 from $15 at Maxim
4M ago
Longeveron presents study results from CLEAR MIND Phase 2a trial
PremiumThe FlyLongeveron presents study results from CLEAR MIND Phase 2a trial
5M ago
Longeveron to sell 2.24M shares a $4.025 in registered direct offering
Premium
The Fly
Longeveron to sell 2.24M shares a $4.025 in registered direct offering
5M ago
Longeveron receives Fast Track Designation for Lomecel-B in mild Alzheimer’s
Premium
The Fly
Longeveron receives Fast Track Designation for Lomecel-B in mild Alzheimer’s
5M ago
Longeveron files to sell 3.56M shares of Class A common stock for holders
PremiumThe FlyLongeveron files to sell 3.56M shares of Class A common stock for holders
6M ago
3 Penny Stocks to Watch Now, 6/18/24
Premium
Market News
3 Penny Stocks to Watch Now, 6/18/24
6M ago
Longeveron announces exercise of warrants for $4.4M gross proceeds
Premium
The Fly
Longeveron announces exercise of warrants for $4.4M gross proceeds
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100